Each filer's latest filing for 36254L308 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Five Narrow Lane LP 13G | 10.0% |
5/14/2025
Event 5/13/2025
|
||
| Cytovance Biologics Inc 13G/A | 9.8% |
10/17/2024
Event 9/30/2024
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
|
Bristol Investment Fund, Ltd.
13G/A
|
2.4% |
6/2/2025
Event 5/29/2025
|
||
| Bristol Investment Fund, Ltd. | 2.4% | |||
| Bristol Capital, LLC | 4.8% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 59 | 2.10 M | $1.02 M |
| 2026 Q1 | 42 | 1.61 M | $657 k |
| 2025 Q4 | 38 | 483 k | $374 k |
| 2025 Q3 | 21 | 374 k | $222 k |
| 2025 Q2 | 22 | 199 k | $711 k |
| 2025 Q1 | 21 | 99.7 k | $220 k |
| 2024 Q4 | 19 | 1.24 M | $29.3 M |
| 2024 Q3 | 17 | 1.25 M | $35.3 M |
| 2024 Q2 | 18 | 1.08 M | $38.1 M |
| 2024 Q1 | 17 | 76.0 k | $351 k |
| 2023 Q4 | 2 | 208 | $53.00 |